Amphastar Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in EUR for Q1 2014

Taxonomy & unit
us-gaap: EUR and USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Amphastar Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate for Q1 2014.
  • Amphastar Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending April 30, 2014 was €3.2M.
Deferred Tax Assets, Valuation Allowance, Quarterly (EUR)
Period Value YoY Chg Change % Date Report Filed
Q1 2014 3.2M Apr 30, 2014 10-K 2017-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.